Profile data is unavailable for this security.
About the company
Delta-Fly Pharma, Inc. is a Japan-based company principally engaged in the research, development, manufacture and sale of pharmaceuticals. The Company's development pipeline includes anticancer drug candidate compound DFP-10917 whose target disease is refractory or recurrent acute myelogenous leukemia, anticancer drug candidate compound DFP-14323 whose target disease is lung cancer, anti-cancer drug candidate compound DFP-11207 whose target disease is solid cancer, anticancer drug candidate compound DFP-14927 whose target disease is solid cancer or blood cancer, anticancer drug candidate compound DFP-10825 whose target disease is peritoneal dissemination metastatic cancer.
- Revenue in JPY (TTM)0.00
- Net income in JPY-1.65bn
- Incorporated2010
- Employees13.00
- LocationDelta-Fly Pharma Inc37-5, Nishikino, Miyajima, Kawauchi-choTOKUSHIMA-SHI 771-0116JapanJPN
- Phone+81 362311278
- Websitehttps://www.delta-flypharma.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Muromachi Chemicals Inc | 6.37bn | 330.20m | 3.13bn | 205.00 | 9.35 | 1.34 | 6.72 | 0.4919 | 81.78 | 81.78 | 1,578.94 | 571.26 | 1.27 | 4.82 | 4.16 | 31,068,770.00 | 6.60 | 5.23 | 10.39 | 10.08 | 29.12 | 30.02 | 5.18 | 4.39 | 1.62 | 40.73 | 0.3876 | 22.95 | 1.24 | 3.28 | 28.83 | 62.76 | -7.95 | -- |
Liberta Co Ltd | 7.89bn | -20.40m | 3.48bn | 118.00 | -- | 2.26 | 24.65 | 0.4409 | -3.49 | -3.49 | 1,325.93 | 256.06 | 1.21 | 2.88 | 5.72 | 66,877,950.00 | -0.3155 | 3.75 | -0.6765 | 6.42 | 37.15 | 41.81 | -0.2615 | 2.37 | 0.8419 | -- | 0.7196 | 35.67 | 6.77 | 9.76 | -2.77 | -12.85 | 23.12 | -- |
Kubota Pharmaceutical Holdings Co Ltd | 32.44m | -1.41bn | 3.55bn | 12.00 | -- | 1.75 | -- | 109.59 | -25.21 | -25.21 | 0.5784 | 36.04 | 0.0106 | 0.2228 | -- | 2,703,333.00 | -46.21 | -36.51 | -50.76 | -39.47 | 76.16 | -- | -4,358.35 | -13,528.87 | 8.51 | -- | 0.0604 | -- | 383.24 | -- | 26.11 | -- | 24.38 | -- |
Immuno-Biological Laboratories Co., Ltd. | 869.12m | 226.88m | 3.96bn | 57.00 | 17.45 | 3.01 | 73.82 | 4.55 | 24.36 | 24.36 | 93.32 | 141.37 | 0.5582 | 0.9352 | 4.06 | 15,247,630.00 | 14.57 | -13.97 | 17.43 | -16.39 | 65.48 | 57.73 | 26.11 | -39.23 | 3.58 | -- | 0.1542 | -- | 2.78 | 0.8924 | 164.44 | -- | -- | -- |
Renascience Inc | 140.67m | -277.45m | 4.02bn | 4.00 | -- | 2.53 | -- | 28.56 | -21.83 | -21.83 | 11.07 | 125.06 | 0.0659 | -- | 18.27 | 35,166,500.00 | -13.00 | -- | -13.28 | -- | 78.84 | -- | -197.24 | -- | -- | -- | 0.187 | -- | 93.11 | -- | 23.07 | -- | -- | -- |
Delta-Fly Pharma Inc | 0.00 | -1.65bn | 4.30bn | 13.00 | -- | 5.88 | -- | -- | -214.95 | -214.95 | 0.00 | 89.00 | 0.00 | -- | -- | 0.00 | -204.19 | -67.70 | -226.67 | -72.02 | -- | -- | -- | -877.69 | -- | -406.70 | 0.00 | -- | -- | -- | -7.57 | -- | -9.04 | -- |
MEDRx Co Ltd | 254.05m | -511.95m | 4.36bn | 22.00 | -- | 1.63 | -- | 17.15 | -13.76 | -13.76 | 6.54 | 56.60 | 0.119 | 0.00 | 19.15 | 11,547,680.00 | -23.98 | -58.15 | -24.39 | -62.23 | 8.88 | 95.70 | -201.52 | -1,526.17 | 52.29 | -- | 0.00 | -- | -50.35 | 28.60 | 16.04 | -- | -55.29 | -- |
NIPPON CHEMIPHAR CO., LTD. | 31.21bn | -133.00m | 6.82bn | 887.00 | -- | 0.3142 | 5.28 | 0.2186 | -36.85 | -36.85 | 8,647.86 | 5,095.28 | 0.6053 | 2.06 | 2.79 | 35,182,640.00 | -0.258 | 0.7482 | -0.3663 | 1.08 | 25.57 | 30.99 | -0.4262 | 1.13 | 1.53 | -- | 0.4954 | 50.73 | -2.57 | -2.10 | -153.10 | -- | 24.62 | -12.94 |
COSMO BIO COMPANY, LIMITED | 9.64bn | 339.00m | 6.96bn | 155.00 | 19.82 | 0.7333 | 14.18 | 0.722 | 58.08 | 58.08 | 1,651.14 | 1,569.72 | 0.8536 | 6.07 | 3.81 | 62,206,450.00 | 3.11 | 5.62 | 3.62 | 6.72 | 33.17 | 37.40 | 3.64 | 6.23 | 6.28 | -- | 0.002 | 33.53 | -2.23 | 5.16 | -14.51 | 11.20 | -8.03 | 16.47 |
Wakamoto Pharmaceutical Co Ltd | 7.76bn | -3.16m | 8.57bn | 274.00 | -- | 0.7115 | 20.94 | 1.10 | -0.0911 | -0.0911 | 223.67 | 345.76 | 0.5017 | 2.07 | 2.98 | 28,330,810.00 | -0.0205 | -2.28 | -0.0233 | -2.64 | 47.07 | 51.00 | -0.0408 | -3.97 | 3.64 | -- | 0.0083 | -- | -10.65 | -6.35 | -21.19 | -- | 4.93 | -- |
Data as of Oct 11 2024. Currency figures normalised to Delta-Fly Pharma Inc's reporting currency: Japanese Yen JPY